Valget af terapeutisk behandlingsstrategi mellem monoterapi og kombinationsbehandling bør overvejes på ny, så snart de mikrobiologiske resultater foreligger, og de lokale retningslinjer bør tillade en tilpasning af anvendelsen af ciprofloxacin.
The adequacy of the therapeutic strategy between monotherapy and combination therapy should be re-considered as soon as microbiological results become available and local guidelines should allow to adequately adapt the ciprofloxacin use.